carbamazepine
Commercial- Indications
- HLA-B*1502 testing for adverse reactions
Company intelligence / Profile preview
Pharmigene has developed and commercialized a range of pharmacogenomic tests that help predict and prevent adverse drug reactions. Their products have received regulatory approvals in Taiwan, China, Singapore, and Europe. Clinical validation studies have involved thousands of patients. The company also developed COVID‑19 antigen rapid tests during the pandemic[5].
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmigene.